Medical Oncologist

Conditions Treated:

MSK medical oncologist Connie Lee Batlevi

About Me

  • Clinical Expertise: Hodgkin Lymphoma and Non-Hodgkin lymphoma
  • Languages Spoken: English
  • Education: MD, PhD, University of Massachusetts
  • Residencies: Mount Sinai Hospital
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Oncology

New Patient Appointments

Making an appointment

Call 800-525-2225

See My Colleagues


Batlevi C, Horwitz SM, Moskowitz CH, Zelenetz AD, Palomba L, et al. “Targeted Genomic Sequencing Prospectively Identifies Clinically Relevant Genetic Alterations Across Lymphoma Subtypes”; 13th International Conference on Malignant Lymphoma, Lugano, Switzerland, 2015. Oral Abstract.1.   

Batlevi CW, Kasamon Y, Bociek RG, Lee P, Gore L, Copeland A, Sorensen R, Ordentlich P, Cruickshank S, Kunkel L, Buglio D, Hernandez-Ilizaliturri F, Younes A. “ENGAGE- 501: Phase 2 Study of Entinostat (SNDX-275) in Relapsed and Refractory Hodgkin Lymphoma.” Haematologica. Epub 2016/05/05. pii: haematol.2016.142406. PMID: 27151994.

Read more

Batlevi CL, Younes A. Novel therapy for Hodgkin lymphoma. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2013;2013:394-9. Epub 2013/12/10. doi: 10.1182/asheducation-2013.1.394. PubMed PMID: 24319210.

Batlevi CL, Younes A. Diffuse large B-cell lymphoma: changing treatment paradigms. Oncology (Williston Park, NY). 2014;28(4):339-41. Epub 2014/05/21. PubMed PMID: 24839810.

Batlevi CL, Anas Y. “Hodgkin lymphoma microenvironment: old and new therapeutic targets”, Lymphoma, Volume 2, Future Medicine, 2014; 36-55. Ebook ISBN: 978-1-78084-582-1

Batlevi CL, Matsuki E, Brentjens RJ, Younes A. Novel immunotherapies in lymphoid malignancies. Nature reviews Clinical oncology. 2016;13(1):25-40. Epub 2015/11/04. doi: 10.1038/nrclinonc.2015.187. PubMed PMID: 26525683.

Visit PubMed for a full listing of Connie Lee Batlevi’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more